<p>COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment</p>
Xinyu Zhu, Yang Liu, Kai Huang
Abstract
The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients.
Topics & Concepts
ObesityMedicineEpidemiologyCoronavirus disease 2019 (COVID-19)OverweightPandemicPathogenesisMetabolic syndromePublic healthInflammationImmune systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineImmunologyDiseasePathologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Adipokines, Inflammation, and Metabolic Diseases